Group One Trading
XBIT icon

Group One Trading’s XBiotech XBIT Stock Holding History

Group One Trading’s Portfolio XBIT Stock Details XBIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.5K Buy
+4,900
New +$11.9K ﹤0.01% 6297
2024
Q4 		– Sell
-1,000
Closed -$7.73K – 8055
2024
Q3 		$7.73K Buy
+1,000
New +$6.57K ﹤0.01% 5716
2023
Q3 		– Sell
-1,900
Closed -$11.3K – 8406
2023
Q2 		$11.3K Buy
+1,900
New +$8.57K ﹤0.01% 6335
2022
Q3 		– Sell
-1,200
Closed -$7K – 8346
2022
Q2 		$7K Sell
1,200
-100
-8% -$673 ﹤0.01% 6963
2022
Q1 		$11K Buy
1,300
+900
+225% +$9.03K ﹤0.01% 7130
2021
Q4 		$4K Buy
400
+100
+33% +$1.3K ﹤0.01% 7734
2021
Q3 		$4K Sell
300
-8,200
-96% -$131K ﹤0.01% 7829
2021
Q2 		$141K Sell
8,500
-1,600
-16% -$27.1K ﹤0.01% 5603
2021
Q1 		$173K Buy
10,100
+4,400
+77% +$82.1K ﹤0.01% 5175
2020
Q4 		$89K Buy
5,700
+1,300
+30% +$24K ﹤0.01% 4656
2020
Q3 		$84K Sell
4,400
-18,000
-80% -$311K ﹤0.01% 4317
2020
Q2 		$307K Buy
22,400
+8,800
+65% +$124K ﹤0.01% 3024
2020
Q1 		$144K Buy
13,600
+9,500
+232% +$155K ﹤0.01% 3007
2019
Q4 		$77K Buy
+4,100
New +$52.8K ﹤0.01% 3802
2019
Q3 		– Sell
-2,000
Closed -$15K – 5618
2019
Q2 		$15K Sell
2,000
-100
-5% -$870 ﹤0.01% 4289
2019
Q1 		$23K Hold
2,100
– – ﹤0.01% 3967
2018
Q4 		$11K Sell
2,100
-30,600
-94% -$126K ﹤0.01% 4247
2018
Q3 		$104K Buy
32,700
+31,300
+2,236% +$122K ﹤0.01% 3510
2018
Q2 		$6K Sell
1,400
-10,300
-88% -$46.5K ﹤0.01% 4782
2018
Q1 		$63K Sell
11,700
-5,300
-31% -$24.4K ﹤0.01% 3541
2017
Q4 		$67K Buy
17,000
+5,600
+49% +$23.6K ﹤0.01% 3576
2017
Q3 		$50K Sell
11,400
-26,100
-70% -$123K ﹤0.01% 3642
2017
Q2 		$176K Sell
37,500
-32,300
-46% -$309K ﹤0.01% 2731
2017
Q1 		$1.15M Buy
69,800
+45,700
+190% +$598K 0.01% 1246
2016
Q4 		$244K Buy
24,100
+23,400
+3,343% +$311K ﹤0.01% 2288
2016
Q3 		$9K Buy
+700
New +$10.3K ﹤0.01% 4082

Other funds holding XBIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Group One Trading's XBIT Position: Q1 2025 in Review

Group One Trading sold out of XBiotech (XBIT) in Q1 2025, closing a stake of 7,500 shares — an estimated $29.6K sold.

Group One Trading first reported a position in XBIT in Q3 2016 and held it in 24 quarters. The position peaked at $474K in Q3 2020. 55 funds tracked by Wall St. Rank hold XBIT as of Q1 2025.

  • Group One Trading reported no remaining XBiotech position as of Q1 2025 after selling out during the quarter.
  • Group One Trading sold 7,500 XBiotech shares in Q1 2025, an estimated $29.6K.
  • Group One Trading first reported a position in XBiotech in Q3 2016 and held it in 24 quarters.
  • Group One Trading's XBiotech position peaked at $474K in Q3 2020.
  • 55 funds tracked by Wall St. Rank held XBiotech as of Q1 2025.

Based on Group One Trading's 13F filing for Q1 2025, filed 14 May 2025.